Provided by Tiger Trade Technology Pte. Ltd.

Protagenic Therapeutics Inc

0.3500
-0.1400-28.57%
Volume:40.08K
Turnover:12.40K
Market Cap:677.21K
PE:-0.07
High:0.4605
Open:0.4605
Low:0.2500
Close:0.4900
52wk High:14.28
52wk Low:0.2500
Shares:1.93M
Float Shares:1.91M
Volume Ratio:4.78
T/O Rate:2.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.3030
EPS(LYR):-15.7868
ROE:-512.79%
ROA:-189.60%
PB:-7.67
PE(LYR):-0.02

Loading ...

Company Profile

Company Name:
Protagenic Therapeutics Inc
Exchange:
PINK
Establishment Date:
2004
Employees:
- -
Office Location:
701 Anacapa Street,Suite C,Santa Barbara,California,United States
Zip Code:
93101
Fax:
- -
Introduction:
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.